Loading…

Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2

Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relati...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2005-06, Vol.65 (11), p.4852-4860
Main Authors: AHMED-BELKACEM, Abdelhakim, POZZA, Alexandre, MUNOZ-MARTINEZ, Francisco, BATES, Susan E, CASTANYS, Santiago, GAMARRO, Francisco, DI PIETRO, Attilio, PEREZ-VICTORIA, José M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3
cites cdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3
container_end_page 4860
container_issue 11
container_start_page 4852
container_title Cancer research (Chicago, Ill.)
container_volume 65
creator AHMED-BELKACEM, Abdelhakim
POZZA, Alexandre
MUNOZ-MARTINEZ, Francisco
BATES, Susan E
CASTANYS, Santiago
GAMARRO, Francisco
DI PIETRO, Attilio
PEREZ-VICTORIA, José M
description Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.
doi_str_mv 10.1158/0008-5472.CAN-04-1817
format article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_00313594v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67891290</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</originalsourceid><addsrcrecordid>eNpFkd2OEyEcxYnRuHX1ETTcaOLFrHwOcNlt3F2TRm_0mlD4T4qZzlRgmsyr-LQytuleAYffOXwchN5Tckep1F8IIbqRQrG7zfp7Q0RDNVUv0IpKrhslhHyJVlfmBr3J-XddSkrka3RDpeGEk3aF_j707jQOYww4lzT5MiVonC_xFMtcpSlEyDgGGErsZtw2xwTD3Pt9mnMcsBsCLuDLeBUyPo6l0v-38hF87KLHcdjHXSxjynjs8C6BywV7N3hIOEGOuSxzfEzVW1PW95tH9ha96lyf4d1lvEW_Hr7-3Dw12x-P3zbrbeOFlqoRToAgRreKKcmZd9rw-j6mOFOMKaJDZ0JoveqgYwE8GOkFaYMKzDDHgN-iz-fcvevtMcWDS7MdXbRP661dNEI45dKIE63spzNbb_pnglzsIWYPfe8GGKdsW6UNZYZUUJ5Bn8acE3TXZErsUqBdyrFLObYWaImwS4HV9-FywLQ7QHh2XRqrwMcL4LJ3fZfqx8X8zLVatsYo_g-teaXQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67891290</pqid></control><display><type>article</type><title>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</title><source>EZB Electronic Journals Library</source><creator>AHMED-BELKACEM, Abdelhakim ; POZZA, Alexandre ; MUNOZ-MARTINEZ, Francisco ; BATES, Susan E ; CASTANYS, Santiago ; GAMARRO, Francisco ; DI PIETRO, Attilio ; PEREZ-VICTORIA, José M</creator><creatorcontrib>AHMED-BELKACEM, Abdelhakim ; POZZA, Alexandre ; MUNOZ-MARTINEZ, Francisco ; BATES, Susan E ; CASTANYS, Santiago ; GAMARRO, Francisco ; DI PIETRO, Attilio ; PEREZ-VICTORIA, José M</creatorcontrib><description>Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-04-1817</identifier><identifier>PMID: 15930306</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Acridines - pharmacology ; Adenosine Triphosphatases - metabolism ; Antineoplastic agents ; ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism ; ATP Binding Cassette Transporter, Subfamily G, Member 2 ; ATP-Binding Cassette Transporters - antagonists &amp; inhibitors ; ATP-Binding Cassette Transporters - genetics ; Benzimidazoles - pharmacokinetics ; Biochemistry, Molecular Biology ; Biological and medical sciences ; Cell Line ; Cell Line, Tumor ; Drug Resistance, Neoplasm ; Flavonoids - chemistry ; Flavonoids - pharmacology ; Humans ; Life Sciences ; Medical sciences ; Mitoxantrone - pharmacokinetics ; Mitoxantrone - pharmacology ; Multidrug Resistance-Associated Proteins - metabolism ; Neoplasm Proteins - antagonists &amp; inhibitors ; Neoplasm Proteins - genetics ; Pharmacology. Drug treatments ; Rhodamines - pharmacokinetics ; Structure-Activity Relationship ; Tetrahydroisoquinolines - pharmacology ; Transfection ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4852-4860</ispartof><rights>2005 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</citedby><cites>FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</cites><orcidid>0000-0001-6489-5091</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16856997$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15930306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-00313594$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>AHMED-BELKACEM, Abdelhakim</creatorcontrib><creatorcontrib>POZZA, Alexandre</creatorcontrib><creatorcontrib>MUNOZ-MARTINEZ, Francisco</creatorcontrib><creatorcontrib>BATES, Susan E</creatorcontrib><creatorcontrib>CASTANYS, Santiago</creatorcontrib><creatorcontrib>GAMARRO, Francisco</creatorcontrib><creatorcontrib>DI PIETRO, Attilio</creatorcontrib><creatorcontrib>PEREZ-VICTORIA, José M</creatorcontrib><title>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.</description><subject>Acridines - pharmacology</subject><subject>Adenosine Triphosphatases - metabolism</subject><subject>Antineoplastic agents</subject><subject>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</subject><subject>ATP Binding Cassette Transporter, Subfamily G, Member 2</subject><subject>ATP-Binding Cassette Transporters - antagonists &amp; inhibitors</subject><subject>ATP-Binding Cassette Transporters - genetics</subject><subject>Benzimidazoles - pharmacokinetics</subject><subject>Biochemistry, Molecular Biology</subject><subject>Biological and medical sciences</subject><subject>Cell Line</subject><subject>Cell Line, Tumor</subject><subject>Drug Resistance, Neoplasm</subject><subject>Flavonoids - chemistry</subject><subject>Flavonoids - pharmacology</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Medical sciences</subject><subject>Mitoxantrone - pharmacokinetics</subject><subject>Mitoxantrone - pharmacology</subject><subject>Multidrug Resistance-Associated Proteins - metabolism</subject><subject>Neoplasm Proteins - antagonists &amp; inhibitors</subject><subject>Neoplasm Proteins - genetics</subject><subject>Pharmacology. Drug treatments</subject><subject>Rhodamines - pharmacokinetics</subject><subject>Structure-Activity Relationship</subject><subject>Tetrahydroisoquinolines - pharmacology</subject><subject>Transfection</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNpFkd2OEyEcxYnRuHX1ETTcaOLFrHwOcNlt3F2TRm_0mlD4T4qZzlRgmsyr-LQytuleAYffOXwchN5Tckep1F8IIbqRQrG7zfp7Q0RDNVUv0IpKrhslhHyJVlfmBr3J-XddSkrka3RDpeGEk3aF_j707jQOYww4lzT5MiVonC_xFMtcpSlEyDgGGErsZtw2xwTD3Pt9mnMcsBsCLuDLeBUyPo6l0v-38hF87KLHcdjHXSxjynjs8C6BywV7N3hIOEGOuSxzfEzVW1PW95tH9ha96lyf4d1lvEW_Hr7-3Dw12x-P3zbrbeOFlqoRToAgRreKKcmZd9rw-j6mOFOMKaJDZ0JoveqgYwE8GOkFaYMKzDDHgN-iz-fcvevtMcWDS7MdXbRP661dNEI45dKIE63spzNbb_pnglzsIWYPfe8GGKdsW6UNZYZUUJ5Bn8acE3TXZErsUqBdyrFLObYWaImwS4HV9-FywLQ7QHh2XRqrwMcL4LJ3fZfqx8X8zLVatsYo_g-teaXQ</recordid><startdate>20050601</startdate><enddate>20050601</enddate><creator>AHMED-BELKACEM, Abdelhakim</creator><creator>POZZA, Alexandre</creator><creator>MUNOZ-MARTINEZ, Francisco</creator><creator>BATES, Susan E</creator><creator>CASTANYS, Santiago</creator><creator>GAMARRO, Francisco</creator><creator>DI PIETRO, Attilio</creator><creator>PEREZ-VICTORIA, José M</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0001-6489-5091</orcidid></search><sort><creationdate>20050601</creationdate><title>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</title><author>AHMED-BELKACEM, Abdelhakim ; POZZA, Alexandre ; MUNOZ-MARTINEZ, Francisco ; BATES, Susan E ; CASTANYS, Santiago ; GAMARRO, Francisco ; DI PIETRO, Attilio ; PEREZ-VICTORIA, José M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acridines - pharmacology</topic><topic>Adenosine Triphosphatases - metabolism</topic><topic>Antineoplastic agents</topic><topic>ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism</topic><topic>ATP Binding Cassette Transporter, Subfamily G, Member 2</topic><topic>ATP-Binding Cassette Transporters - antagonists &amp; inhibitors</topic><topic>ATP-Binding Cassette Transporters - genetics</topic><topic>Benzimidazoles - pharmacokinetics</topic><topic>Biochemistry, Molecular Biology</topic><topic>Biological and medical sciences</topic><topic>Cell Line</topic><topic>Cell Line, Tumor</topic><topic>Drug Resistance, Neoplasm</topic><topic>Flavonoids - chemistry</topic><topic>Flavonoids - pharmacology</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Medical sciences</topic><topic>Mitoxantrone - pharmacokinetics</topic><topic>Mitoxantrone - pharmacology</topic><topic>Multidrug Resistance-Associated Proteins - metabolism</topic><topic>Neoplasm Proteins - antagonists &amp; inhibitors</topic><topic>Neoplasm Proteins - genetics</topic><topic>Pharmacology. Drug treatments</topic><topic>Rhodamines - pharmacokinetics</topic><topic>Structure-Activity Relationship</topic><topic>Tetrahydroisoquinolines - pharmacology</topic><topic>Transfection</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AHMED-BELKACEM, Abdelhakim</creatorcontrib><creatorcontrib>POZZA, Alexandre</creatorcontrib><creatorcontrib>MUNOZ-MARTINEZ, Francisco</creatorcontrib><creatorcontrib>BATES, Susan E</creatorcontrib><creatorcontrib>CASTANYS, Santiago</creatorcontrib><creatorcontrib>GAMARRO, Francisco</creatorcontrib><creatorcontrib>DI PIETRO, Attilio</creatorcontrib><creatorcontrib>PEREZ-VICTORIA, José M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AHMED-BELKACEM, Abdelhakim</au><au>POZZA, Alexandre</au><au>MUNOZ-MARTINEZ, Francisco</au><au>BATES, Susan E</au><au>CASTANYS, Santiago</au><au>GAMARRO, Francisco</au><au>DI PIETRO, Attilio</au><au>PEREZ-VICTORIA, José M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2005-06-01</date><risdate>2005</risdate><volume>65</volume><issue>11</issue><spage>4852</spage><epage>4860</epage><pages>4852-4860</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>Overexpression of breast cancer resistance protein ABCG2 confers multidrug resistance in cancer cells. The GF120918-sensitive drug efflux activity of human wild-type (R482) ABCG2-transfected cells was used for rational screening of inhibitory flavonoids and establishment of structure-activity relationships. Flavones were found more efficient than flavonols, isoflavones, and flavanones. Differentially substituted flavone derivatives indicated positive OH effects at position 5, in contrast to positions 3 and 7. A methoxy at position 7 was slightly positive in tectochrysin, whereas a strong positive effect was produced by prenylation at position 6. The potency of 6-prenylchrysin was comparable with that of GF120918 (IC50 = 0.3 micromol/L). Both 6-prenylchrysin and tectochrysin seemed specific for ABCG2 because no interaction was detected with either P-glycoprotein or MRP1. The ABCG2 resistance profile in vitro is altered by mutation at amino acid 482. The R482T mutation limited the effect of prenylation on ABCG2 inhibition. Whereas GF120918 strongly inhibited the ATPase activity of wild-type ABCG2, neither 6-prenylchrysin nor tectochrysin altered the activity. In contrast, all three inhibitors stimulated the ATPase activity of mutant ABCG2. 6-Prenylchrysin at 0.5 micromol/L efficiently sensitized the growth of wild-type ABCG2-transfected cells to mitoxantrone, whereas higher concentrations were required for the mutant ones. In contrast, 1 micromol/L tectochrysin was sufficient to fully sensitize mutant ABCG2-transfected cells, whereas higher concentrations were required for the wild-type ones. Both flavones exhibited a lower intrinsic cytotoxicity than GF120918 and were apparently not transported by ABCG2. 6-Prenylchrysin and tectochrysin therefore constitute new and promising inhibitors for the reversal of ABCG2-mediated drug transport.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15930306</pmid><doi>10.1158/0008-5472.CAN-04-1817</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-6489-5091</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2005-06, Vol.65 (11), p.4852-4860
issn 0008-5472
1538-7445
language eng
recordid cdi_hal_primary_oai_HAL_hal_00313594v1
source EZB Electronic Journals Library
subjects Acridines - pharmacology
Adenosine Triphosphatases - metabolism
Antineoplastic agents
ATP Binding Cassette Transporter, Subfamily B, Member 1 - metabolism
ATP Binding Cassette Transporter, Subfamily G, Member 2
ATP-Binding Cassette Transporters - antagonists & inhibitors
ATP-Binding Cassette Transporters - genetics
Benzimidazoles - pharmacokinetics
Biochemistry, Molecular Biology
Biological and medical sciences
Cell Line
Cell Line, Tumor
Drug Resistance, Neoplasm
Flavonoids - chemistry
Flavonoids - pharmacology
Humans
Life Sciences
Medical sciences
Mitoxantrone - pharmacokinetics
Mitoxantrone - pharmacology
Multidrug Resistance-Associated Proteins - metabolism
Neoplasm Proteins - antagonists & inhibitors
Neoplasm Proteins - genetics
Pharmacology. Drug treatments
Rhodamines - pharmacokinetics
Structure-Activity Relationship
Tetrahydroisoquinolines - pharmacology
Transfection
Tumors
title Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T23%3A27%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Flavonoid%20structure-activity%20studies%20identify%206-prenylchrysin%20and%20tectochrysin%20as%20potent%20and%20specific%20inhibitors%20of%20breast%20cancer%20resistance%20protein%20ABCG2&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=AHMED-BELKACEM,%20Abdelhakim&rft.date=2005-06-01&rft.volume=65&rft.issue=11&rft.spage=4852&rft.epage=4860&rft.pages=4852-4860&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-04-1817&rft_dat=%3Cproquest_hal_p%3E67891290%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4857-4a4e40986727532ca8931592732722708df9dd6c7fef2dece95c406d7d292a2e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67891290&rft_id=info:pmid/15930306&rfr_iscdi=true